Prevalence, Outcomes, and Management of Ventricular Arrhythmias in COVID-19 Patients

Nicola Tarantino; Domenico G. Della Rocca; Fengwei Zou; Aung Lin; Andrea Natale; Luigi Di Biase

doi:10.1016/j.ccep.2021.10.002

Prevalence, Outcomes, and Management of Ventricular Arrhythmias in COVID-19 Patients

Nicola Tarantino, Domenico G. Della Rocca, Fengwei Zou, Aung Lin, Andrea Natale, Luigi Di Biase

Medicine

Research output: Contribution to journal › Review article › peer-review

2 Scopus citations

Abstract

We review the current data on epidemiology, the clinical significance, the pathophysiologic mechanisms, and the treatment of VAs in the setting of COVID-19. VAs prevail in 0.15% to 8% of hospitalized patients, but only sustained and rapid tachyarrhythmias are purportedly associated with a significant increase in mortality. Multiple factors can elicit VAs, which are ultimately deemed to be a marker of severe systemic disease rather than a distinct cardiac condition. Even though the electrophysiologist plays a determinant role in the secondary prevention of VAs, a multidisciplinary approach is indispensable for primary prophylaxis and acute management.

Original language	English (US)
Pages (from-to)	11-20
Number of pages	10
Journal	Cardiac Electrophysiology Clinics
Volume	14
Issue number	1
DOIs	https://doi.org/10.1016/j.ccep.2021.10.002
State	Published - Mar 2022

Keywords

Arrhythmias
COVID-19
Complications
Management
Outcomes
SARS-CoV-2
Ventricular tachycardia

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine
Physiology (medical)

Access to Document

10.1016/j.ccep.2021.10.002

Cite this

@article{777229ffb81540e48f145285846c11ac,

title = "Prevalence, Outcomes, and Management of Ventricular Arrhythmias in COVID-19 Patients",

abstract = "We review the current data on epidemiology, the clinical significance, the pathophysiologic mechanisms, and the treatment of VAs in the setting of COVID-19. VAs prevail in 0.15% to 8% of hospitalized patients, but only sustained and rapid tachyarrhythmias are purportedly associated with a significant increase in mortality. Multiple factors can elicit VAs, which are ultimately deemed to be a marker of severe systemic disease rather than a distinct cardiac condition. Even though the electrophysiologist plays a determinant role in the secondary prevention of VAs, a multidisciplinary approach is indispensable for primary prophylaxis and acute management.",

keywords = "Arrhythmias, COVID-19, Complications, Management, Outcomes, SARS-CoV-2, Ventricular tachycardia",

author = "Nicola Tarantino and {Della Rocca}, {Domenico G.} and Fengwei Zou and Aung Lin and Andrea Natale and {Di Biase}, Luigi",

note = "Funding Information: Dr A. Natale has received speaker honoraria from Boston Scientific, Biosense Webster, St. Jude Medical, Biotronik, and Medtronic; and is a consultant for Biosense Webster, St. Jude Medical, and Janssen. Dr L. Di Biase is a consultant for Biosense Webster, RMG, Stereotaxis, Boston Scientific, and Abbott. Dr L. Di Biase received speaker honoraria/travel from Medtronic, Atricure, and Biotronik. All other authors have reported that they have no relationships relevant to the contents of this article to disclose.",

year = "2022",

month = mar,

doi = "10.1016/j.ccep.2021.10.002",

language = "English (US)",

volume = "14",

pages = "11--20",

journal = "Cardiac Electrophysiology Clinics",

issn = "1877-9182",

publisher = "W.B. Saunders Ltd",

number = "1",

}

TY - JOUR

T1 - Prevalence, Outcomes, and Management of Ventricular Arrhythmias in COVID-19 Patients

AU - Tarantino, Nicola

AU - Della Rocca, Domenico G.

AU - Zou, Fengwei

AU - Lin, Aung

AU - Natale, Andrea

AU - Di Biase, Luigi

N1 - Funding Information: Dr A. Natale has received speaker honoraria from Boston Scientific, Biosense Webster, St. Jude Medical, Biotronik, and Medtronic; and is a consultant for Biosense Webster, St. Jude Medical, and Janssen. Dr L. Di Biase is a consultant for Biosense Webster, RMG, Stereotaxis, Boston Scientific, and Abbott. Dr L. Di Biase received speaker honoraria/travel from Medtronic, Atricure, and Biotronik. All other authors have reported that they have no relationships relevant to the contents of this article to disclose.

PY - 2022/3

Y1 - 2022/3

N2 - We review the current data on epidemiology, the clinical significance, the pathophysiologic mechanisms, and the treatment of VAs in the setting of COVID-19. VAs prevail in 0.15% to 8% of hospitalized patients, but only sustained and rapid tachyarrhythmias are purportedly associated with a significant increase in mortality. Multiple factors can elicit VAs, which are ultimately deemed to be a marker of severe systemic disease rather than a distinct cardiac condition. Even though the electrophysiologist plays a determinant role in the secondary prevention of VAs, a multidisciplinary approach is indispensable for primary prophylaxis and acute management.

AB - We review the current data on epidemiology, the clinical significance, the pathophysiologic mechanisms, and the treatment of VAs in the setting of COVID-19. VAs prevail in 0.15% to 8% of hospitalized patients, but only sustained and rapid tachyarrhythmias are purportedly associated with a significant increase in mortality. Multiple factors can elicit VAs, which are ultimately deemed to be a marker of severe systemic disease rather than a distinct cardiac condition. Even though the electrophysiologist plays a determinant role in the secondary prevention of VAs, a multidisciplinary approach is indispensable for primary prophylaxis and acute management.

KW - Arrhythmias

KW - COVID-19

KW - Complications

KW - Management

KW - Outcomes

KW - SARS-CoV-2

KW - Ventricular tachycardia

UR - http://www.scopus.com/inward/record.url?scp=85125428719&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85125428719&partnerID=8YFLogxK

U2 - 10.1016/j.ccep.2021.10.002

DO - 10.1016/j.ccep.2021.10.002

M3 - Review article

C2 - 35221078

AN - SCOPUS:85125428719

SN - 1877-9182

VL - 14

SP - 11

EP - 20

JO - Cardiac Electrophysiology Clinics

JF - Cardiac Electrophysiology Clinics

IS - 1

ER -

Prevalence, Outcomes, and Management of Ventricular Arrhythmias in COVID-19 Patients

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this